Stock Earnings

Question 1

What are Whitehawk Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Whitehawk Therapeutics Inc has a total asset of $70, Net loss of $-63

Question 2

What are the key financial ratios for WHWK?

Accepted Answer

Whitehawk Therapeutics Inc's Current ratio is 4.11, has a Net margin is -252, sales per share of $0.92.

Question 3

How is Whitehawk Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Whitehawk Therapeutics Inc data is not available.

Question 4

Is Whitehawk Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Whitehawk Therapeutics Inc has a net loss of $-63

Question 5

Does Whitehawk Therapeutics Inc have any liabilities?

Accepted Answer

yes, Whitehawk Therapeutics Inc has liability of 17

Question 6

How many outstanding shares for Whitehawk Therapeutics Inc?

Accepted Answer

Whitehawk Therapeutics Inc has a total outstanding shares of 24.68

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	14	25	24	15	1	15
Revenue Growth (YoY)	-44%	4%	60%	1,400%	-93%	--
Cost of Revenue	1	3	2	1	--	--
Gross Profit	12	22	21	13	--	--
Selling, General & Admin	35	36	44	40	18	8
Research & Development	86	51	48	32	19	12
Operating Expenses	121	87	93	72	38	21
Other Non Operating Income (Expenses)	0	--	--	--	--	1
Pretax Income	-15	-63	-65	-60	-110	-4
Income Tax Expense	0	0	0	0	0	--
Net Income	-15	-63	-65	-60	-110	-4
Net Income Growth	-75%	-3%	8%	-45%	2,650%	-83%
Shares Outstanding (Diluted)	69.2	27.02	26.91	22.51	8.92	2.84
Shares Change (YoY)	156%	0%	20%	152%	214%	5%
EPS (Diluted)	-0.22	-2.35	-2.44	-2.69	-12.34	-1.52
EPS Growth	-90%	-4%	-9%	-78%	712%	-82%
Free Cash Flow	-95	-61	-63	-50	-22	-5
Free Cash Flow Per Share	-1.37	-2.25	-2.34	-2.22	-2.46	-1.76
Gross Margin	85.71%	88%	87.5%	86.66%	--	--
Operating Margin	-771.42%	-256%	-295.83%	-386.66%	-3,700%	-40%
Profit Margin	-107.14%	-252%	-270.83%	-400%	-11,000%	-26.66%
Free Cash Flow Margin	-678.57%	-244%	-262.5%	-333.33%	-2,200%	-33.33%
EBITDA	-108	-64	-71	-58	-37	-6
EBITDA Margin	-771.42%	-256%	-295.83%	-386.66%	-3,700%	-40%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-108	-64	-71	-58	-37	-6
EBIT Margin	-771.42%	-256%	-295.83%	-386.66%	-3,700%	-40%
Effective Tax Rate	0%	0%	0%	0%	0%	--

Whitehawk Therapeutics Inc (WHWK) Price